Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study

Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity

(2015) Rujipas Sirijatuphat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Association Between Colistin Dose and Development of Nephrotoxicity*

(2015) Yu-Ji Lee et al.   CRITICAL CARE MEDICINE

In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy

(2014) K. Phe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Validation of a Model To Predict the Risk of Nephrotoxicity in Patients Receiving Colistin

(2014) Kady Phe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Lycopene Attenuates Colistin-Induced Nephrotoxicity in Mice via Activation of the Nrf2/HO-1 Pathway

(2014) Chongshan Dai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin-Induced Nephrotoxicity in Mice Involves the Mitochondrial, Death Receptor, and Endoplasmic Reticulum Pathways

(2014) Chongshan Dai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

(2014) Alpha A Fowler et al.   Journal of Translational Medicine

Colistin nephrotoxicity increases with age

(2014) Ilker Inanc Balkan et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

How Does Colistin-Induced Nephropathy Develop and Can It Be Treated?

(2013) Gulsum Ozkan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study

(2013) Luisa Sorlí et al.   BMC INFECTIOUS DISEASES

Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center

(2013) Darowan S. Akajagbor et al.   CLINICAL INFECTIOUS DISEASES

Surviving Sepsis Campaign

(2013) R. Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

(2013) Felipe F. Tuon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Emergent Renal Dysfunction with Colistin Pharmacotherapy

(2013) Julie M. Collins et al.   PHARMACOTHERAPY

Evaluation of colistin nephrotoxicity administered at different doses in the rat model

(2013) Zohra Ghlissi et al.   RENAL FAILURE

Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients

(2012) Timothy P. Gauthier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia

(2012) Giulia Vicari et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary: Closing the Loop--A Colistin Clinical Study to Confirm Dosing Recommendations From PK/PD Modeling

(2012) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study

(2012) L. Dalfino et al.   CLINICAL INFECTIOUS DISEASES

References

(2012)   Kidney International Supplements

Melatonin Attenuates Colistin-Induced Nephrotoxicity in Rats

(2011) Jumana M. Yousef et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

(2011) S. M. Garonzik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System

(2011) J. M. Pogue et al.   CLINICAL INFECTIOUS DISEASES

Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics

(2011) J. M. Yousef et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients

(2011) Neha M Doshi et al.   PHARMACOTHERAPY

Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital

(2010) C. A. DeRyke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine?

(2010) Ezgi Ozyilmaz et al.   INTENSIVE CARE MEDICINE

Predictors of acute kidney injury associated with intravenous colistin treatment

(2010) Jeong-Ah Kwon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models

(2010) R. V. Dudhani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center

(2009) Joshua D. Hartzell et al.   CLINICAL INFECTIOUS DISEASES

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Plasma antioxidant status in septic critically ill patients: a decrease over time

(2008) Jean-Marc Doise et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY